Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated (VRTX) on the NASDAQ Exchange
Company overview
Vertex Pharmaceuticals Incorporated is a publicly listed company from USA with shares traded on NASDAQ under the ticker VRTX. This page provides a live view of market pricing and an interactive chart to follow short and long-term moves without manual refresh. The latest streaming quotes for VRTX are bid 461.99 USD and ask 463.56 USD.
Use the chart to review recent momentum, identify key price areas, and track how Vertex Pharmaceuticals Incorporated is performing relative to your portfolio in 2025. If you are researching the instrument for trading or investing, add VRTX to your watchlist in R StocksTrader and compare it with other US and European shares, indices, and metals.
Key facts
- Exchange: NASDAQ
- Company: Vertex Pharmaceuticals Incorporated
- Ticker: VRTX
- Country: USA
- Bid: 461.99 USD
- Ask: 463.56 USD
- Quotes: real-time, auto-updated
Risk
Risk Warning: Past performance of VRTX does not predict future returns.
FAQ
Open a trading account at RoboForex, decide on the number of assets to buy, and then place an order for Vertex Pharmaceuticals Incorporated (VRTX) in R StocksTrader. Create and verify your profile, fund the account, search for VRTX, and choose the instrument type available to you. Add VRTX to your Watchlist to track moves and manage open positions throughout 2025.
VRTX trades on NASDAQ and is issued by Vertex Pharmaceuticals Incorporated. This page provides a live chart and continuously updated price data for the 2025 year so that you can follow intraday swings and longer trends. Before starting trading and placing orders, review trading hours, typical spreads, and fees in the terminal to make sure conditions for VRTX match your plan.
Quotes update automatically in real time. Current levels for VRTX are bid 461.99 USD and ask 463.56 USD. The spread is the difference between ask and bid and affects your effective entry and exit. Track VRTX in R StocksTrader and adjust your approach as market conditions change in 2025.